Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Aethlon Medical (AEMD) over the last 15 years, with Q1 2025 value amounting to $72443.0.

  • Aethlon Medical's Share-based Compensation fell 4792.77% to $72443.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $415234.0, marking a year-over-year decrease of 6594.68%. This contributed to the annual value of $415234.0 for FY2025, which is 6594.68% down from last year.
  • Per Aethlon Medical's latest filing, its Share-based Compensation stood at $72443.0 for Q1 2025, which was down 4792.77% from $89970.0 recorded in Q4 2024.
  • Over the past 5 years, Aethlon Medical's Share-based Compensation peaked at $572955.0 during Q4 2023, and registered a low of $72443.0 during Q1 2025.
  • For the 5-year period, Aethlon Medical's Share-based Compensation averaged around $211019.9, with its median value being $201062.0 (2021).
  • Per our database at Business Quant, Aethlon Medical's Share-based Compensation surged by 11817.47% in 2023 and then plummeted by 8429.72% in 2024.
  • Quarter analysis of 5 years shows Aethlon Medical's Share-based Compensation stood at $201019.0 in 2021, then soared by 30.64% to $262613.0 in 2022, then surged by 118.17% to $572955.0 in 2023, then crashed by 84.3% to $89970.0 in 2024, then dropped by 19.48% to $72443.0 in 2025.
  • Its last three reported values are $72443.0 in Q1 2025, $89970.0 for Q4 2024, and $113493.0 during Q3 2024.